Baylor College of Medicine
One Baylor Plaza
Houston
Texas
77030
United States
Tel: 713-798-4951
Website: http://www.bcm.tmc.edu/
Email: www@bcm.tmc.edu
189 articles with Baylor College of Medicine
-
Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
9/23/2020
Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine.
-
As we head into cold and flu season, the question arises: Can you get COVID-19 and the flu at the same time?
-
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
5/27/2020
Company will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates
-
Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
5/21/2020
Mymetics Corporation announced that its subsidiary, Mymetics BV, has signed a Research Collaboration Agreement with Baylor College of Medicine and Texas Children's Center for Vaccine Development for evaluating their rationally designed recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combining them with Mymetics' virosomes for the development of a safe and effective Covid-19 vaccine.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19
3/23/2020
AlloVir’s proprietary technology is designed to develop virus specific T-cell therapies with potential to treat and prevent several devastating viral diseases with each single cell therapy product
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
7/20/2019
Results show potential of MultiTAA therapy in combination with chemotherapy as a first-line treatment for patients with pancreatic cancer; potential second-line treatment for chemo-refractory patients
-
Here are some of the top research stories that happened around the industry this week.
-
Cell Medica Collaborators, Baylor College of Medicine and Texas Children’s Hospital, Present Preclinical Data for an off-the-shelf CAR-NKT Therapy Platform at American Society of Gene & Cell Therapy 22nd Annual Meeting
5/1/2019
Allogeneic “off the shelf” chimeric antigen receptor-natural killer T cell (CAR-NKT) therapy platform could overcome significant challenges of current autologous CAR-T therapies
-
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
4/30/2019
Preclinical, 'proof-of-concept' results for a novel 'all-in-one' immunotherapy for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-positive solid tumors
-
Cell Medica Collaborator, Baylor College of Medicine, Showcasing Promise of CAR-NKT Therapies at American Society of Gene & Cell Therapy 22nd Annual Meeting
4/17/2019
Collaboration with Baylor College of Medicine and Texas Children’s Hospital includes ground-breaking GINAKIT2 Phase 1 trial
-
The recent CBRE Research report, “2019 U.S. Life Sciences Clusters” has two Texas metropolitan areas in its top-10 fastest-growing life sciences market. Houston ranked third, while Dallas/Ft. Worth ranked seventh. Let’s look at Dallas/Ft. Worth.
-
The American Association for Cancer Research (AACR) Annual Meeting is taking place in Atlanta. Here’s a look at just a few stories coming out of the meeting.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Absence epilepsy is the most common type of seizure disorder in children and is the focus of a new neurology study at Baylor College of Medicine and published in the journal Nature Communications.
-
MilliporeSigma And Baylor College of Medicine Advance Vaccine Development And Manufacturing For Neglected Diseases
8/8/2017
-
ViraCyte Enters Exclusive License Agreement With Baylor College of Medicine For T Cell Immunotherapies Targeting Viruses
7/18/2017
-
Baylor College of Medicine Release: Anti-Alpha-Synuclein Antibody Is A Potential Disease-Modifying Treatment For Parkinson’s Disease
6/12/2017